TaiMed Biologics Strategic Asset Allocation Index
TaiMed Biologics strategic asset allocation index. TaiMed Biologics (4147) has a Strategic Asset Allocation Index of 35.1% as of June 2023. Strategic assets (PP&E of NT$930.02 Million plus long-term investments of NT$-) total NT$930.02 Million, measured against net assets of NT$2.65 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 4147 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of TaiMed Biologics (2009–2022)
Strategic asset allocation index of TaiMed Biologics from 2009 to 2022. This chart shows how TaiMed Biologics's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 35.1%, representing strategic assets of NT$930.02 Million against net assets of NT$2.65 Billion TWD.
TaiMed Biologics Strategic Asset Allocation Index by Year (2009–2022)
TaiMed Biologics strategic asset allocation index by year from 2009 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for TaiMed Biologics from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 4147 company net worth.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.3% | NT$957.74 Million | NT$957.74 Million | NT$- | NT$2.71 Billion | ▲ +0.9 pp |
| 2021 | 34.4% | NT$1.01 Billion | NT$1.01 Billion | NT$- | NT$2.94 Billion | ▲ +3.2 pp |
| 2020 | 31.2% | NT$1.06 Billion | NT$1.06 Billion | NT$- | NT$3.42 Billion | ▼ -2.0 pp |
| 2019 | 33.2% | NT$1.19 Billion | NT$940.32 Million | NT$249.36 Million | NT$3.59 Billion | ▲ +0.7 pp |
| 2018 | 32.5% | NT$1.33 Billion | NT$863.18 Million | NT$462.53 Million | NT$4.08 Billion | ▲ +21.3 pp |
| 2017 | 11.2% | NT$479.34 Million | NT$315.09 Million | NT$164.25 Million | NT$4.29 Billion | ▲ +10.5 pp |
| 2016 | 0.6% | NT$29.27 Million | NT$19.27 Million | NT$10.00 Million | NT$4.71 Billion | ▲ +0.3 pp |
| 2015 | 0.3% | NT$15.99 Million | NT$15.99 Million | NT$- | NT$4.90 Billion | ▼ -0.6 pp |
| 2014 | 0.9% | NT$16.21 Million | NT$16.21 Million | NT$- | NT$1.83 Billion | ▲ +0.4 pp |
| 2013 | 0.5% | NT$3.17 Million | NT$3.17 Million | NT$- | NT$657.73 Million | ▼ -0.3 pp |
| 2012 | 0.8% | NT$4.84 Million | NT$4.84 Million | NT$- | NT$645.21 Million | ▲ +0.2 pp |
| 2011 | 0.5% | NT$4.25 Million | NT$4.25 Million | NT$- | NT$839.24 Million | ▼ 0.0 pp |
| 2010 | 0.5% | NT$5.45 Million | NT$5.45 Million | NT$- | NT$1.04 Billion | ▼ -0.5 pp |
| 2009 | 1.0% | NT$6.06 Million | NT$6.06 Million | NT$- | NT$598.14 Million | — |